ArticleCognitive neuroscience
Open and cautious towards the "minority view".
Article in Cognitive neuroscience. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the 'minority view', the initial afferent processing on C1 can be modulated by attention under certain experimental conditions. However, evidence supporting this 'minority view' is relatively rare and needs more replication, and the optimal conditions for eliciting attentional modulations on C1 have not yet been clearly defined. V1-tuned stimuli with distractors, peripheral cuing paradigms, and high perceptual loads seem to be important factors in favor of the 'minority view'. The signal-noise issue for C1, especially between attended and unattended conditions, needs to be considered.
Indexed as
Identifiers
28874090What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.